The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The Tuberculosis Cascade of Care in India’s Public Sector: A Systematic Review and Meta-analysis
Open accessAbstract
BACKGROUND: India has 23% of the global burden of active tuberculosis (TB) patients and 27% of the world's "missing" patients, which includes those who may not have received effective TB care and could potentially spread TB to others. The "cascade of care" is a useful model for visualizing deficiencies in case detection and retention in care, in order to prioritize interventions. METHODS AND FINDINGS: The care cascade constructed in this paper focuses on the Revised National TB Control Programme (RNTCP), which treats about half of India's TB patients. We define the TB cascade as including the following patient populations: total prevalent active TB patients in India, TB patients who reach and undergo evaluation at RNTCP diagnostic facilities, patients successfully diagnosed with TB, patients who start treatment, patients retained to treatment completion, and patients who achieve 1-y recurrence-free survival. We estimate each step of the cascade for 2013 using data from two World Health Organization (WHO) reports (2014-2015), one WHO dataset (2015), and three RNTCP reports (2014-2016). In addition, we conduct three targeted systematic reviews of the scientific literature to identify 39 unique articles published from 2000-2015 that provide additional data on five indicators that help estimate different steps of the TB cascade. We construct separate care cascades for the overall population of patients with active TB and for patients with specific forms of TB-including new smear-positive, new smear-negative, retreatment smear-positive, and multidrug-resistant (MDR) TB. The WHO estimated that there were 2,700,000 (95%CI: 1,800,000-3,800,000) prevalent TB patients in India in 2013. Of these patients, we estimate that 1,938,027 (72%) TB patients were evaluated at RNTCP facilities; 1,629,906 (60%) were successfully diagnosed; 1,417,838 (53%) got registered for treatment; 1,221,764 (45%) completed treatment; and 1,049,237 (95%CI: 1,008,775-1,083,243), or 39%, of 2,700,000 TB patients achieved the optimal outcome of 1-y recurrence-free survival. The separate cascades for different forms of TB highlight different patterns of patient attrition. Pretreatment loss to follow-up of diagnosed patients and post-treatment TB recurrence were major points of attrition in the new smear-positive TB cascade. In the new smear-negative and MDR TB cascades, a substantial proportion of patients who were evaluated at RNTCP diagnostic facilities were not successfully diagnosed. Retreatment smear-positive and MDR TB patients had poorer treatment outcomes than the general TB population. Limitations of our analysis include the lack of available data on the cascade of care in the private sector and substantial uncertainty regarding the 1-y period prevalence of TB in India. CONCLUSIONS: Increasing case detection is critical to improving outcomes in India's TB cascade of care, especially for smear-negative and MDR TB patients. For new smear-positive patients, pretreatment loss to follow-up and post-treatment TB recurrence are considerable points of attrition that may contribute to ongoing TB transmission. Future multisite studies providing more accurate information on key steps in the public sector TB cascade and extension of this analysis to private sector patients may help to better target interventions and resources for TB control in India.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
Self-citationContact investigation for tuberculosis: a systematic review and meta-analysis
Fox, G. J., Barry, S. E., Britton, W. J., & Marks, G. B. (2013) · European Respiratory Journal · doi:10.1183/09031936.00070812 · Cited by 709
Yehia, B. R., Schranz, A. J., Umscheid, C. A., & Lo Re, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101554 · Cited by 440
Rate of Reinfection Tuberculosis after Successful Treatment Is Higher than Rate of New Tuberculosis
Verver, S., Warren, R. M., Beyers, N., Richardson, M., van der Spuy, G. D., Borgdorff, M. W., Enarson, D. A., Behr, M. A., & van Helden, P. D. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1200oc · Cited by 439
Das, J., Holla, A., Das, V., Mohanan, M., Tabak, D., & Chan, B. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1356 · Cited by 424
Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review
Sreeramareddy, C. T., Qin, Z. Z., Satyanarayana, S., Subbaraman, R., & Pai, M. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0585 · Cited by 378
Self-citationXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253
Self-citationA review of the diagnosis and treatment of smear-negative pulmonary tuberculosis.
Colebunders, R., & Bastian, I. (2000) · PubMed · Cited by 239
Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study
Das, J., Kwan, A., Daniels, B., Satyanarayana, S., Subbaraman, R., Bergkvist, S., Das, R. K., Das, V., & Pai, M. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00077-8 · Cited by 237
Self-citationMase, S., Ramsay, A., Ng, V., Henry, M., Hopewell, P. C., Cunningham, J., Urbanczik, R., Perkins, M. D., Aziz, M. A., & Pai, M. (2007) · PubMed · Cited by 224
Self-citationLaw, I., Floyd, K., & the African TB Prevalence Survey Group (2020) · Tropical Medicine & International Health · doi:10.1111/tmi.13485 · Cited by 207
Nosyk, B., Montaner, J. S. G., Colley, G., Lima, V. D., Chan, K., Heath, K., Yip, B., Samji, H., Gilbert, M., Barrios, R., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70254-8 · Cited by 206
Yuen, C. M., Amanullah, F., Dharmadhikari, A., Nardell, E. A., Seddon, J. A., Vasilyeva, I., Zhao, Y., Keshavjee, S., & Becerra, M. C. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00322-0 · Cited by 201
Gender disparities in tuberculosis: report from a rural DOTS programme in south India.
Balasubramanian, R., Garg, R. M., Santha, T., et al. (2004) · PubMed · Cited by 194
Thomas, A., Gopi, P. G., Santha, T., Chandrasekaran, V., Subramani, R., Selvakumar, N., Eusuff, S. I., Sadacharam, K., & Narayanan, P. R. (2005) · PubMed · Cited by 193
A Cascade of Care for Diabetes in the United States: Visualizing the Gaps
Ali, M. K., Bullard, K. M., Gregg, E. W., & del Rio, C. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0019 · Cited by 182
Onozaki, I., Law, I., Sismanidis, C., Zignol, M., Glaziou, P., & Floyd, K. (2015) · Tropical Medicine & International Health · doi:10.1111/tmi.12534 · Cited by 163
Shah, N., Yuen, C. M., Heo, M., Tolman, A. W., & Becerra, M. C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit643 · Cited by 161
Quality of tuberculosis care in India: a systematic review
Satyanarayana, S., Subbaraman, R., Shete, P. B., Gore, G. C., Das, J., Cattamanchi, A., Mayer, K. H., Menzies, D., Harries, A. D., Hopewell, P. C., et al. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.15.0186 · Cited by 131
Self-citationCost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India
Floyd, K., Arora, V. K., Murthy, K. J. R., Lönnroth, K., Singla, N., Akbar, Y. H., Zignol, M., & Uplekar, M. W. (2006) · Bulletin of the World Health Organization · doi:10.2471/blt.05.024109 · Cited by 104
Mistry, N. F., Rangan, S., Dholakia, Y. N., Lobo, E., Shah, S. U., & Patil, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152287 · Cited by 102
Sachdeva, K. S., Raizada, N., Sreenivas, A., Hoog, A. H. V., van den Hof, S., Dewan, P. K., Thakur, R., Gupta, R. S., Kulsange, S., Vadera, B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126065 · Cited by 97
Contribution of reinfection to recurrent tuberculosis in South African gold miners.
Charalambous, S., Grant, A. D., Moloi, V., Warren, R. M., Day, J. H., van Helden, P. D., Hayes, R., Fielding, K., Cock, K. M. D., Chaisson, R. E., et al. (2008) · PubMed · Cited by 94
Timing of relapse in short-course chemotherapy trials for tuberculosis.
Nunn, A., Phillips, P. P. J., & Mitchison, D. A. (2010) · PubMed · Cited by 90
Kranzer, K., Lawn, S. D., Meyer‐Rath, G., Vassall, A., Raditlhalo, E., Govindasamy, D., van Schaik, N., Wood, R., & Bekker, L. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001281 · Cited by 77
Hazarika, I. (2011) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.77291 · Cited by 72
Babu, B. S., Satyanarayana, S., Venkateshwaralu, G., et al. (2008) · PubMed · Cited by 60
Self-citationPrevalence of Pulmonary Tuberculosis - A Baseline Survey In Central India
Rao, V. G., Bhat, J., Yadav, R., Gopalan, G. P., Selvakumar, N., Bhondeley, M. K., Anjinappa, S. M., Ramchandra, J., Chadha, V. K., & Wares, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043225 · Cited by 56
Self-citationJain, S., Sankar, M. M., Sharma, N., Singh, S., & Chugh, T. D. (2014) · Pathogens and Global Health · doi:10.1179/2047773214y.0000000133 · Cited by 55
Prevalence of pulmonary tuberculosis amongst the tribal population of Madhya Pradesh, central India
Bhat, J., Rao, V. G., Gopi, P. G., Yadav, R., Selvakumar, N., Tiwari, B., Gadge, V. V., Bhondeley, M. K., & Wares, F. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp222 · Cited by 51
Thomas, B. E., Velayutham, B., Thiruvengadam, K., Nair, D., Barman, S. B., Jayabal, L., Ovung, S., & Swaminathan, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147579 · Cited by 45
Self-citationGopi, P. G., Chandrasekaran, Subramani, R., et al. (2005) · NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis) · Cited by 37
Sharma, S. K., Soneja, M., Prasad, K., & Ranjan, S. (2014) · Europe PMC (PubMed Central) · Cited by 37
Prevalence of Pulmonary Tuberculosis among Adults in a Rural Sub-District of South India
Chadha, V. K., Kumar, P., Anjinappa, S. M., Singh, S. P., Narasimhaiah, S., Joshi, M. V., Gupta, J., Lakshminarayana, Ramchandra, J., Velu, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042625 · Cited by 37
Self-citationTripathy, J. P., Satyanarayana, S., Naidoo, P., Ananthakrishnan, R., & Bhaskar, R. (2013) · Public Health Action · doi:10.5588/pha.13.0044 · Cited by 32
Self-citationShringarpure, K. S., Isaakidis, P., Sagili, K. D., & Baxi, R. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132543 · Cited by 31
Improving the estimation of the tuberculosis burden in India
Cowling, K., Dandona, R., & Dandona, L. (2014) · Bulletin of the World Health Organization · doi:10.2471/blt.13.129775 · Cited by 31
Thomas, B. E., Charles, N., Watson, B., Chandrasekaran, V., Kumar, R. S., Dhanalakshmi, A., Wares, F., & Swaminathan, S. (2014) · Journal of Public Health · doi:10.1093/pubmed/fdu104 · Cited by 27
Self-citationMcDowell, A., & Pai, M. (2016) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trw009 · Cited by 18
Self-citationSatyanarayana, S., Nair, S. A., Chadha, S. S., Sharma, G., Yadav, S., Mohanty, S. K., Kamineni, V., Wilson, N. C., & Harries, A. D. (2012) · Public Health Action · doi:10.5588/pha.12.0019 · Cited by 16
Self-citationMarket assessment of tuberculosis diagnostics in China in 2012
Zhao, Y.-L., Pang, Y., Xia, H., Du, X., Chin, D. P., Huan, S.-T., Dong, H.-Y., Zhang, Z.-Y., Ginnard, J., Perkins, M. D., et al. (2016) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.15.0156 · Cited by 15
Self-citationSilva, D. R., Müller, A. M., Tomasini, K. D. S., Dalcin, P. D. T. R., Golub, J. E., & Conde, M. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107576 · Cited by 12
Cited by
High-quality health systems in the Sustainable Development Goals era: time for a revolution
Kruk, M. E., Gage, A. D., Arsenault, C., Jordan, K., Leslie, H. H., Roder-DeWan, S., Adeyi, O., Barker, P., Daelmans, B., Doubova, S. V., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30386-3 · Cited by 4,057
Furin, J., Cox, H., & Pai, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30308-3 · Cited by 873
Self-citationBuilding a tuberculosis-free world: The Lancet Commission on tuberculosis
Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30024-8 · Cited by 361
Self-citationManagement of drug-resistant tuberculosis
Lange, C., Dheda, K., Chesov, D., Mandalakas, A. M., Udwadia, Z., & Horsburgh, C. R. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31882-3 · Cited by 299
The South African tuberculosis care cascade: Estimated losses and methodological challenges
Naidoo, P., Theron, G., Rangaka, M. X., Chihota, V. N., Vaughan, L., Brey, Z. O., & Pillay, Y. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix335 · Cited by 238
“Although the concept of continuity of care [35, 36] and attrition along the care pathway has been deliberated in tuberculosis control for many years, there are few published data that quantify outcomes [37, 38].”
BackgroundResultInfluential
Metadata
- Authors
- Subbaraman, R., Nathavitharana, R. R., Satyanarayana, S., Pai, M., Thomas, B. E., Chadha, V. K., Rade, K., Swaminathan, S., & Mayer, K. H.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-10-25
- Volume
- 13
- Issue
- 10
- Pages
- e1002149
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2533279624
- Cited by
- 274
- References
- 43
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.